1. Metabolomics Analysis of L-Arginine Induced Gastrointestinal Motility Disorder in Rats Using UPLC-MS After Magnolol Treatment
   Xiao Wang et al, 2019, Front. Pharmacol. CrossRef
2. PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases
   Márcia V. de Carvalho et al, 2021, IJMS CrossRef
3. Ovomucin Ameliorates Intestinal Barrier and Intestinal Bacteria to Attenuate DSS-Induced Colitis in Mice
   Aobai Tu et al, 2021, J. Agric. Food Chem. CrossRef
4. Prophylactic and therapeutic potential of magnolol-loaded PLGA-PEG nanoparticles in a chronic murine model of allergic asthma
   Junyi Wang et al, 2023, Front. Bioeng. Biotechnol. CrossRef
5. An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease
   Xi Fan et al, 2023, ACS Nano CrossRef
6. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
   Balaji Venkataraman et al, 2020, Phytother Res CrossRef